Related Experiment Videos

Interferon-gamma mediates long-term persistent Chlamydia psittaci infection in vitro

J Brown1, G Entrican

  • 1Moredun Research Institute, Edinburgh, UK.

Insights

Recombinant ovine interferon gamma (rOvIFN-gamma) shows long-term anti-chlamydial effects. Higher concentrations of rOvIFN-gamma were microbicidal against Chlamydia psittaci, but lower doses allowed pathogen re-emergence.

Area of Science:

  • Veterinary Medicine
  • Immunology
  • Microbiology

Background:

  • Chlamydia psittaci is an important veterinary pathogen.
  • Interferon gamma is a key cytokine in immune responses.
  • Understanding long-term effects of treatments is crucial for disease control.

Purpose of the Study:

  • To investigate the long-term anti-chlamydial effects of recombinant ovine interferon gamma (rOvIFN-gamma).
  • To determine the minimum effective concentration and duration of rOvIFN-gamma treatment against Chlamydia psittaci.

Main Methods:

  • Ovine ST-6 fibroblasts were infected with Chlamydia psittaci.
  • Recombinant ovine interferon gamma (rOvIFN-gamma) was applied at various concentrations.
  • Chlamydial multiplication was assessed using ELISA, IFU titrations, and inclusion body enumeration.

Main Results:

  • rOvIFN-gamma at 250 and 1000 U/ml exhibited microbistatic effects, becoming microbicidal after 14 days.
  • Lower concentrations (25 and 100 U/ml) inhibited growth but allowed chlamydiae re-emergence upon removal.
  • Re-emergence was faster at 25 U/ml compared to 100 U/ml, leading to fibroblast death.

Conclusions:

  • Sustained high-dose rOvIFN-gamma can achieve microbicidal activity against Chlamydia psittaci.
  • Intermittent or low-dose rOvIFN-gamma may not provide complete eradication and risks pathogen re-emergence.
  • Further research into optimal dosing and duration for effective Chlamydia psittaci treatment is warranted.

Related Concept Videos